Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodie McVernon

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Expert Review of Vaccines|December 18, 2010
Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009Jodie McVernon, Terry Nolan
BMJ (Clinical Research Ed.)|April 4, 2014
Introducing a new group B meningococcus vaccineDavid Isaacs, Jodie McVernon
BMJ (Clinical Research Ed.)|March 6, 2023
WHO keeps covid-19 a public health emergency of international concernJodie McVernon, Jonathan Liberman
Mathematical Biosciences|April 10, 2007
Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemicJames M McCaw, Jodie McVernon
American Journal of Epidemiology|April 29, 2017
Determining the Best Strategies for Maternally Targeted Pertussis Vaccination Using an Individual-Based ModelPatricia Therese Campbell, Jodie McVernon, Nicholas Geard
Plos One|February 25, 2011
Diagnosis and antiviral intervention strategies for mitigating an influenza epidemicRobert Moss, James M McCaw, Jodie McVernon
The Lancet. Infectious Diseases|January 15, 2004
T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccinationJodie McVernon, N Avrion Mitchison, E Richard Moxon
Infectious Diseases and Therapy|August 20, 2014
A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate VaccineKirsten P Perrett, Terry M Nolan, Jodie McVernon
Human Vaccines & Immunotherapeutics|February 26, 2015
Pertussis models to inform vaccine policyPatricia T Campbell, James M McCaw, Jodie McVernon
Emerging Infectious Diseases|January 1, 2014
A historical perspective of influenza A(H1N2) virusNaomi Komadina, Jodie McVernon, Robert Hall, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Expert Review of Vaccines|December 18, 2010
Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009Jodie McVernon, Terry Nolan
BMJ (Clinical Research Ed.)|April 4, 2014
Introducing a new group B meningococcus vaccineDavid Isaacs, Jodie McVernon
BMJ (Clinical Research Ed.)|March 6, 2023
WHO keeps covid-19 a public health emergency of international concernJodie McVernon, Jonathan Liberman
Mathematical Biosciences|April 10, 2007
Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemicJames M McCaw, Jodie McVernon
American Journal of Epidemiology|April 29, 2017
Determining the Best Strategies for Maternally Targeted Pertussis Vaccination Using an Individual-Based ModelPatricia Therese Campbell, Jodie McVernon, Nicholas Geard
Plos One|February 25, 2011
Diagnosis and antiviral intervention strategies for mitigating an influenza epidemicRobert Moss, James M McCaw, Jodie McVernon
The Lancet. Infectious Diseases|January 15, 2004
T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccinationJodie McVernon, N Avrion Mitchison, E Richard Moxon
Infectious Diseases and Therapy|August 20, 2014
A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate VaccineKirsten P Perrett, Terry M Nolan, Jodie McVernon
Human Vaccines & Immunotherapeutics|February 26, 2015
Pertussis models to inform vaccine policyPatricia T Campbell, James M McCaw, Jodie McVernon
Emerging Infectious Diseases|January 1, 2014
A historical perspective of influenza A(H1N2) virusNaomi Komadina, Jodie McVernon, Robert Hall, et al.
Pageof 17